AbCellera Biologics Inc. company logo
AbCellera Biologics Inc. logo

AbCellera Biologics Inc. (ABCL) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$156.33M$23.01M+17.26%

Summary

Current Value
As of today, ABCL annual cash & cash equivalents is $156.33M, up +17.26% on
Historical Performance
ABCL annual cash & cash equivalents is down -67.17% over the past 3 years, and up +1969.71% over the past 5 years
All-Time High Comparison
ABCL annual cash & cash equivalents is currently -73.69% below its historical high of $594.12M set on
3-Year Low Comparison
ABCL annual cash & cash equivalents is +17.26% above its 3-year low of $133.32M reached on
Sector Comparison
ABCL annual cash & cash equivalents is higher than 73.45% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ABCL Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$156.33M+17.3%-67.2%+1969.7%+1396.8%
Quarterly Cash & Cash Equivalents$520.67M-22.1%-41.7%+471.6%
Price$4.27+42.3%-58.9%-90.3%
Annual Current Assets$751.37M-13.8%-19.2%+5844.4%+4855.6%
Annual Total Liabilities$154.58M-35.6%-47.2%+1067.8%+1464.1%
Annual Working Capital$674.76M-10.4%-16.6%+10000.0%+7630.2%
Annual Net Income-$162.86M-11.2%-206.1%-7266.8%-10000.0%

Cash and Cash Equivalents Highs

ABCL Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$386.54MN/A-59.6%
5Y$594.12MN/A-73.7%
All$594.12M-73.7%

Cash and Cash Equivalents Lows

ABCL Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$133.32M+17.3%
5Y$133.32M+17.3%
All$7.55M+1969.7%

Cash and Cash Equivalents History

YearValueChange
$156.33M+17.3%
$133.32M-65.5%
$386.54M-18.8%
$476.14M-19.9%
YearValueChange
$594.12M+7,766.0%
$7.55M-27.7%
$10.44M-

FAQ

  • What is the current annual cash & cash equivalents of ABCL?

    As of today, ABCL annual cash & cash equivalents is $156.33M

  • What is 1-year change in ABCL annual cash & cash equivalents?

    ABCL annual cash & cash equivalents is up +17.26% year-over-year

  • What is 3-year change in ABCL annual cash & cash equivalents?

    ABCL annual cash & cash equivalents is down -67.17% over the past 3 years

  • How far is ABCL annual cash & cash equivalents from its all-time high?

    ABCL annual cash & cash equivalents is currently -73.69% below its historical high of $594.12M set on December 31, 2020

  • How does ABCL annual cash & cash equivalents rank versus sector peers?

    ABCL annual cash & cash equivalents is higher than 73.45% of companies in Healthcare sector

  • When is ABCL next annual earnings release?

    The next annual earnings release for ABCL is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. ABCL Official Website www.abcellera.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1703057/000170305725000025/0001703057-25-000025-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1703057/000162828025008689/0001628280-25-008689-index.htm
  4. ABCL Profile on Yahoo Finance finance.yahoo.com/quote/ABCL
  5. ABCL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abcl